Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance
Mutations in the P53 pathway are a hallmark of human cancer. The identification of pathways upon which p53-deficient cells depend could reveal therapeutic targets that may spare normal cells with intact p53. In contrast to P53 point mutations in other cancer, complete loss of P53 is a frequent event...
Main Authors: | , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
eLife Sciences Publications, Ltd
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854515/ |